Your browser doesn't support javascript.
loading
Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature.
Bonnot, O; Cohen, D; Thuilleaux, D; Consoli, A; Cabal, S; Tauber, M.
Affiliation
  • Bonnot O; Child and Adolescent Psychiatry Department, LPL-University Hospital Nantes and GDR 3557, Psychiatric Institute, 7 quai Moncousu, Nantes, F-44 000, France. olivier.bonnot@chu-nantes.fr.
  • Cohen D; Child and Adolescent Psychiatry Department, Groupe Hospitalier Pitie Salpetriere, APHP, Paris & Centre for Rare Diseases with Psychiatric Symptoms, APHP, 47 boulevard de l'hôpital, Paris, 75013, France. david.cohen@psl.aphp.fr.
  • Thuilleaux D; Rare Disease with Psychiatric Symptoms Department, Hôpital Mari, APHP, Route de la Corniche, Hendaye, 64700, France. denise.thuilleaux@hnd.aphp.fr.
  • Consoli A; Child and Adolescent Psychiatry Department, Groupe Hospitalier Pitie Salpetriere, APHP, Paris & Centre for Rare Diseases with Psychiatric Symptoms, APHP, 47 boulevard de l'hôpital, Paris, 75013, France. angele.consoli@psl.aphp.fr.
  • Cabal S; Child and Adolescent Psychiatry Department, CHU de Toulouse, Toulouse, France. cabal-berthoumieu.s@chu-toulouse.fr.
  • Tauber M; Pediatric Department, University Hospital Toulouse & Rare Disease Center for Prader Willi Syndrome, CHU de Toulouse, Toulouse, France. tauber.mt@chu-toulouse.fr.
Eur J Pediatr ; 175(1): 9-18, 2016 Jan.
Article in En | MEDLINE | ID: mdl-26584571
ABSTRACT
Prader-Willi syndrome (PWS) is a rare genetic syndrome. The phenotype includes moderate to intellectual disability, dysmorphia, obesity, and behavioral disturbances (e.g., hetero and self-injurious behaviors, hyperphagia, psychosis). Psychotropic medications are widely prescribed in PWS for symptomatic control. We conducted a systematic review of published literature to examine psychotropic medications used in PWS. MEDLINE was searched to identify articles published between January 1967 and December 2014 using key words related to pharmacological treatments and PWS. Articles with original data were included based on a standardized four-step selection process. The identification of studies led to 241 records. All selected articles were evaluated for case descriptions (PWS and behavioral signs) and treatment (type, titration, efficiency, and side effects). Overall, 102 patients were included in these studies. Treatment involved risperidone (three reports, n = 11 patients), fluoxetine (five/n = 6), naltrexone (two/n = 2), topiramate (two/n = 16), fluvoxamine (one/n = 1), mazindol (one/n = 2), N-acetyl cysteine (one/n = 35), rimonabant (one/n = 15), and fenfluramine (one/n = 15).

CONCLUSION:

We identified promising treatment effects with topiramate for self-injury and impulsive/aggressive behaviors, risperidone for psychotic symptoms associated with uniparental disomy (UPD), and N-acetyl cysteine for skin picking. The pharmacological approach of behavioral impairment in PWS has been poorly investigated to date. Further randomized controlled studies are warranted. WHAT IS KNOWN Behavioral disturbances in Prader-Willi syndrome including aggressive reactions, skin picking, and hyperphagia might be very difficult to manage. Antipsychotic drugs are widely prescribed, but weight gain and increased appetite are their major side effects. WHAT IS NEW Topiramate might be efficient for self-injury and impulsive/aggressive behaviors, N-acetyl cysteine is apromising treatment for skin picking and Antidepressants are indicated for OCD symptoms. Risperidone is indicated in case of psychotic symptoms mainly associated with uniparental disomy.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Prader-Willi Syndrome / Psychotropic Drugs Type of study: Clinical_trials / Systematic_reviews Limits: Adolescent / Child / Child, preschool / Humans Language: En Journal: Eur J Pediatr Year: 2016 Type: Article Affiliation country: France

Full text: 1 Database: MEDLINE Main subject: Prader-Willi Syndrome / Psychotropic Drugs Type of study: Clinical_trials / Systematic_reviews Limits: Adolescent / Child / Child, preschool / Humans Language: En Journal: Eur J Pediatr Year: 2016 Type: Article Affiliation country: France